Data is not available at this time.
AptarGroup, Inc. operates as a global leader in the design and manufacturing of innovative dispensing, sealing, and active packaging solutions. The company serves diverse industries, including pharmaceuticals, beauty, food, and beverage, leveraging its proprietary technologies to enhance product functionality and consumer convenience. Aptar’s revenue model is driven by recurring sales of high-margin dispensing systems, supported by long-term contracts with blue-chip clients. Its market position is reinforced by strong R&D capabilities, regulatory expertise, and a global manufacturing footprint, enabling it to address complex packaging challenges across regulated and fast-moving consumer sectors. The company’s focus on sustainability and digital integration further strengthens its competitive edge in an evolving packaging landscape.
AptarGroup reported revenue of $3.58 billion for FY 2024, with net income of $374.5 million, reflecting a disciplined cost structure and pricing power. Diluted EPS stood at $5.53, supported by operating cash flow of $643.4 million. Capital expenditures of $294.2 million indicate ongoing investments in capacity and innovation, aligning with long-term growth objectives. The company’s ability to convert revenue into cash underscores operational efficiency.
AptarGroup’s earnings power is evident in its robust operating cash flow, which exceeds net income, highlighting strong working capital management. The company’s capital efficiency is further demonstrated by its ability to fund growth initiatives while maintaining healthy returns. With a focus on high-value segments like pharmaceuticals, Aptar sustains premium margins, reinforcing its earnings durability across economic cycles.
The company maintains a solid balance sheet, with $223.8 million in cash and equivalents against total debt of $1.08 billion. This prudent leverage ratio provides flexibility for strategic investments or acquisitions. Aptar’s consistent cash generation supports debt servicing and shareholder returns, positioning it well for sustained financial stability.
AptarGroup has demonstrated steady growth, driven by demand for innovative packaging in healthcare and consumer markets. Its dividend policy, with a payout of $1.72 per share, reflects a commitment to returning capital to shareholders while retaining funds for reinvestment. The company’s growth trajectory is supported by secular trends like sustainability and digitalization in packaging.
The market values AptarGroup’s consistent execution and niche leadership, as reflected in its earnings multiple. Investors likely price in continued margin resilience and growth in high-barrier segments like pharmaceutical dispensing. The stock’s valuation balances near-term macroeconomic risks with long-term structural demand for Aptar’s solutions.
AptarGroup’s strategic advantages include its technological expertise, global scale, and deep client relationships. The outlook remains positive, with tailwinds from regulatory-driven packaging upgrades and sustainability trends. Challenges include raw material volatility, but the company’s diversified portfolio and innovation pipeline position it to outperform peers over the long term.
Company 10-K, investor presentations
show cash flow forecast
Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
Revenue growth rate, % | NaN | |||||||||||||||||||||||||
Revenue, $ | NaN | |||||||||||||||||||||||||
Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
Total operating expenses, $m | NaN | |||||||||||||||||||||||||
Operating income, $m | NaN | |||||||||||||||||||||||||
EBITDA, $m | NaN | |||||||||||||||||||||||||
Interest expense (income), $m | NaN | |||||||||||||||||||||||||
Earnings before tax, $m | NaN | |||||||||||||||||||||||||
Tax expense, $m | NaN | |||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
Total assets, $m | NaN | |||||||||||||||||||||||||
Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
Average production assets, $m | NaN | |||||||||||||||||||||||||
Working capital, $m | NaN | |||||||||||||||||||||||||
Total debt, $m | NaN | |||||||||||||||||||||||||
Total liabilities, $m | NaN | |||||||||||||||||||||||||
Total equity, $m | NaN | |||||||||||||||||||||||||
Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
Funds from operations, $m | NaN | |||||||||||||||||||||||||
Change in working capital, $m | NaN | |||||||||||||||||||||||||
Cash from operations, $m | NaN | |||||||||||||||||||||||||
Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
New CAPEX, $m | NaN | |||||||||||||||||||||||||
Total CAPEX, $m | NaN | |||||||||||||||||||||||||
Free cash flow, $m | NaN | |||||||||||||||||||||||||
Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
Discount rate, % | NaN | |||||||||||||||||||||||||
PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
Current shareholders' claim on cash, % | NaN |